W. Maniara

发表

Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors.

Paul N. Mortenson, M. Congreve, R. Cheng, 2012, ACS medicinal chemistry letters.

Novel heterocyclic DPP-4 inhibitors for the treatment of type 2 diabetes.

D. E. Clark, C. Higgs, N. Ostermann, 2012, Bioorganic & medicinal chemistry letters.